4.4 Article

Novel peripheral blood parameters as predictors of neoadjuvant chemotherapy response in breast cancer

Related references

Note: Only part of the references are listed.
Article Cell Biology

Prognostic Nutritional Index (PNI) in Patients With Breast Cancer Treated With Neoadjuvant Chemotherapy as a Useful Prognostic Indicator

Li Chen et al.

Summary: The study showed that the PNI value can predict survival and disease progression in breast cancer patients receiving neoadjuvant chemotherapy, with patients having a higher PNI experiencing significantly better DFS and OS. Additionally, PNI has predictive value for both early-stage and advanced breast cancer patients.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)

Review Oncology

The Role of Chronic Inflammation in the Development of Breast Cancer

David N. Danforth

Summary: Chronic inflammation plays a significant role in breast cancer development, with factors like adipose tissue and obesity affecting early stages of carcinogenesis. The microbiome and genomic changes also contribute to inflammation, suggesting a role in the initiation, development, and progression of breast cancer.

CANCERS (2021)

Review Medicine, General & Internal

Breast cancer

Nadia Harbeck et al.

LANCET (2017)

Review Oncology

The immune contexture in cancer prognosis and treatment

Wolf H. Fridman et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2017)

Review Cell Biology

Tumor-Associated Macrophages and Neutrophils in Tumor Microenvironment

Jaehong Kim et al.

MEDIATORS OF INFLAMMATION (2016)

Article Oncology

Diagnostic and Prognostic Importance of the Neutrophil Lymphocyte Ratio in Breast Cancer

Gulzade Ozyalvacli et al.

ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2014)

Review Biochemistry & Molecular Biology

Dangerous liaisons: STAT3 and NF-κB collaboration and crosstalk in cancer

Sergei I. Grivennikov et al.

CYTOKINE & GROWTH FACTOR REVIEWS (2010)